Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A model-informed strategy for long-acting PLGA microspheres: Dog-to-human translation and model-to-model correlation using brexpiprazole as a model drug.

Created on 15 Nov 2026

Authors

Guangyi Leng, Hanyang Wang, Chunjie Sha, Xuemei Zhang, Xin Di

Published in

Journal of controlled release : official journal of the Controlled Release Society. Pages 115548. Nov 14, 2026. Epub Nov 14, 2026.

Abstract

Despite the clinical success of long-acting injectable (LAI) formulations, their development still relies heavily on empirical optimization, which provides limited mechanistic understanding or predictive translation between in vitro and in vivo performance. This study aimed to develop a model-informed strategy for long-acting PLGA microspheres that integrates PopPK modeling and model-to-model correlation to support dog-to-human translation and quantitatively link in vitro release with model-predicted human absorption, using brexpiprazole (BPZ) as a model drug. Monodisperse BPZ-loaded microspheres were prepared via cross-flow membrane emulsification and exhibited a narrow size distribution (span value ≤0.57). In vitro release studies revealed viscosity-dependent biphasic profiles, and pharmacokinetic (PK) studies in Beagle dogs demonstrated consistent rank-order release kinetics and prolonged systemic exposure with increasing polymer viscosity. Because of pronounced interspecies differences in BPZ pharmacokinetics between dogs and humans, PopPK modeling and simulation were used to characterize and compare the PK profiles of BPZ after administration of the oral reference tablet and BPZ-loaded microspheres. The dog PK model was extrapolated to humans using clinically reported and appropriately scaled PK parameters of BPZ. The resulting model-predicted human PK profiles were subsequently employed to establish a model-to-model correlation between in vitro release and model-predicted human absorption. The correlation showed good internal consistency, with prediction errors (%PE) below 10%, indicating a close quantitative relationship between the two model-derived profiles. Overall, this study provides proof of concept for a quantitative, model-informed framework that integrates in vitro release, animal pharmacokinetics, interspecies extrapolation and model-to-model correlation between in vitro release and model-predicted human absorption. This approach highlights the potential of model-informed drug development (MIDD) to improve translational predictability and guide the rational design of LAI antipsychotics.

PMID:
43033922
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement